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Following injury, primary sensory neurons undergo changes that drive central
sensitization and contribute to the maintenance of persistent hypersensitivity. NR2B
expression in the dorsal root ganglia (DRG) has not been previously examined in
neuropathic pain models. Here, we investigated if changes in NR2B expression within
the DRG are associated with hypersensitivities that result from peripheral nerve injuries.
This was done by comparing the NR2B expression in the DRG derived from two
modalities of the spared nerve injury (SNI) model, since each variant produces different
neuropathic pain phenotypes. Using the electronic von Frey to stimulate the spared
and non-spared regions of the hindpaws, we demonstrated that sural-SNI animals
develop sustained neuropathic pain in both regions while the tibial-SNI animals recover.
NR2B expression was measured at Day 23 and Day 86 post-injury. At Day 23
and 86 post-injury, sural-SNI animals display strong hypersensitivity, whereas tibial-
SNI animals display 50 and 100% recovery from post-injury-induced hypersensitivity,
respectively. In tibial-SNI at Day 86, but not at Day 23 the perinuclear region of
the neuronal somata displayed an increase in NR2B protein. This retention of NR2B
protein within the perinuclear region, which will render them non-functional, correlates
with the recovery observed in tibial-SNI. In sural-SNI at Day 86, DRG displayed
an increase in NR2B mRNA which correlates with the development of sustained
hypersensitivity in this model. The increase in NR2B mRNA was not associated
with an increase in NR2B protein within the neuronal somata. The latter may result
from a decrease in kinesin Kif17, since Kif17 mediates NR2B transport to the
soma’s plasma membrane. In both SNIs, microglia/macrophages showed a transient
increase in NR2B protein detected at Day 23 but not at Day 86, which correlates
with the initial post-injury induced hypersensitivity in both SNIs. In tibial-SNI at Day
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86, but not at Day 23, satellite glia cells (SGCs) displayed an increase in NR2B protein.
This study is the first to characterize of cell-specific changes in NR2B expression within
the DRG following peripheral nerve injury. We discuss how the observed NR2B changes
in DRG can contribute to the different neuropathic pain phenotypes displayed by each
SNI variant.
Keywords: NR2B, spared nerve injury, neuropathic pain, sensory neurons, DRG, dorsal root ganglia
INTRODUCTION
In humans with chronic allodynia associated with previous
surgical fields and neuromas, altered central processing is not
autonomous, and appears to depend on continued peripheral
nerve input (Hoffert et al., 1984; Gracely et al., 1992; Gold and
Gebhart, 2010). The development of chronic neuropathic pain
after surgery is often associated with peripheral nerve injury
(Macrae, 2001, 2008). In animal models involving peripheral
nerve injuries, increases in excitability and ectopic discharges
of injured and closely located uninjured nerve fibers, and
from their soma located within the dorsal root ganglia (DRG)
alter the stimuli-evoked afferent input that may drive central
sensitization and contribute to the maintenance of persistent
hypersensitivity (Kingery et al., 1993; Sotgiu and Biella, 1997;
Sukhotinsky et al., 2004; Kovalsky et al., 2009; Smith et al.,
2013). The N-methyl-D-aspartate receptor (NMDAr) is one of
many proteins that have been associated with neuropathic pain.
The NMDAr is one of the three ligand-gated ion channels
activated by glutamate, the major excitatory neurotransmitter
in the brain and spinal cord. The NMDAr is a heterotetramer
consisting of two NR1 and two NR2 subunits. In neurons, the
amount of functional NMDAr is defined by the expression of
the four types of NR2 subunits since neurons contain large
cytoplasmic pools of NR1 subunit (Brose et al., 1993; Petralia
et al., 1994a,b; Hall and Soderling, 1997; Huh and Wenthold,
1999), that are mostly unassociated with NR2 subunits, and
hence non-functional (Chazot and Stephenson, 1997; Huh and
Wenthold, 1999). Using knockout mice and pharmacological
tools, NR2B has been implicated in neuropathic pain (Abe et al.,
2005). Treatment with NR2B-selective antagonists decreases
pain in various animal models of neuropathic pain (Chizh
et al., 2001; Malmberg et al., 2003; Abe et al., 2005; Swartjes
et al., 2011). Compared to general NMDAr blockers, specific
NR2B antagonists display lower central toxicity both in animal
models (sural-SNI, sciatic nerve ligation, spinal nerve ligation,
inflammatory pain; Boyce et al., 1999; Swartjes et al., 2011)
and in clinical trials (Mony et al., 2009), which reflects the
more restricted expression of NR2B in the brain (Watanabe
et al., 1993; Farrant et al., 1994). Various studies suggest that
the action of NR2B antagonists, in part, is mediated by actions
at the spinal cord level. Intrathecal application of an NR2B
antagonist reduces mechanical hypersensitivity following L5-
spinal nerve ligation (Qu et al., 2009). Intrathecal injections
of small interfering RNAs (siRNAs) abolish formalin-induced
pain behaviors and decrease the expression of NR2B in the
spinal cord (Tan et al., 2005; Zhang et al., 2013). In sural-
SNI, oral immunization with anti-NR2B decreases mechanical
hypersensitivity and NR2B expression in the spinal cord (but not
in the brain; Wang et al., 2007). In rats, intrathecal injections
reach both the spinal cord and the closely located DRG (Butler
et al., 2005; Wang et al., 2005). Hence, intrathecal injections
of NR2B blockers and of siRNAs targeting the NR2B, and oral
immunization with anti-NR2B would be expected to reach and
affect not only the spinal cord but also the closely located DRG.
The observed therapeutic benefits of these treatments could
therefore also involve their actions in the DRG. Within the DRG,
the primary sensory neurons (Marvizon et al., 2002; Castillo
et al., 2013) and their surrounding satellite glia cells (Castillo
et al., 2013) express functional NMDAr. Moreover, several lines
of evidence indicate that there is glutamate release within
the sensory ganglia (Battaglia and Rustioni, 1988; Brumovsky
et al., 2007). By using the sniffer patch technique it has been
shown that electrical stimulation appears to elicit glutamate
release from the somata of DRG neurons (Gu et al., 2010);
and reducing glutamine synthase in the trigeminal ganglion
produces analgesia in the formalin test (Jasmin et al., 2010). In
addition, peripheral Schwann cells store and release glutamate
(Parpura et al., 1995; Jeftinija and Jeftinija, 1998). These
observations indicate that there is glutamate release in the
sensory ganglia and peripheral nerves that contributes to the
excitability of peripheral sensory neurons. Since NR2B is the
predominant NR2 subunit within the DRG, in this study we
investigated how NR2B changes in the peripheral DRG are
related to stimuli-evoked hypersensitivities in rats by using two
variants of the spared nerve injury (SNI) model. In contrast to
the tibial-SNI variant, sural-SNI produces robust, long lasting
mechanical and cold allodynia in the ipsilateral paw (Norcini
et al., 2014). We investigated whether sustained mechanical
and cold hypersensitivity resulting from the sural-SNI variant
is accompanied by an increase in NR2B expression within the
DRG.
MATERIALS AND METHODS
Animal Model
Adult male Sprague–Dawley rats (250–400 g) were used following
the guidelines approved by the New York University Langone
Medical Center Institutional Animal Care and Use Committee.
Under isoflurane anesthesia, two different variations of the SNI
were performed as previously described (Decosterd and Woolf,
2000; Norcini et al., 2014). In sham controls, the sciatic nerve
and its branches were only exposed but not manipulated (Norcini
et al., 2014).
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Behavioral Test
Mechanical hypersensitivity was evaluated in individual rats
placed in Plexiglas boxes upon an elevated metal grid allowing
access to the plantar surface of the hind-paws (Norcini et al.,
2014). Rats were “marked” on the top of their tails and
were randomly placed into the individual Plexiglas boxes. The
investigator doing the measurements could not see the “mark”
on the rat’s tail. The individual applying the filament was different
from the individual doing the read out on the electronic von Frey
apparatus. Mechanical thresholds were measured in two regions
of the plantar surfaces of both hindpaws; the middle region which
is mostly innervated by the tibial nerve, and the lateral region
which is mostly innervated by the sural nerve (Duraku et al.,
2012). We also recorded whether the response was accompanied
by a paw withdrawal. Mechanical thresholds were obtained by
using the electronic von Frey apparatus equipped with a size 15
filament fitted on the 800 g arm (IITC Life Sciences, Inc.). The
filament has a uniform flat tip of 0.8 mm in diameter, allowing
a consistent stimulus surface area. When the filament contacts
the paw, the recording unit displays the amount of pressure
applied in grams; this value increases as the pressure being
applied is increased. When the animal withdraws the paw the
maximum grams value is stored in the recording unit; this value,
is referred as the “mechanical threshold.” If at a given applied
pressure the filament starts to bend, without a paw withdrawal,
no additional pressure is applied and a constant maximum grams
value must be maintained for 3 s in order to be recorded as
the “mechanical threshold.” Thus, for each animal, maximum
thresholds are recorded, regardless of the presence of a paw
withdrawal response. Measurements were repeated three times
with an interval of about 3–5 min between stimulations, and
for each animal the mean value was computed. Mean values per
animal were then pooled together according to surgery variant
and day of testing.
Paw Volume Measurements
Paw volumes were measured using a plethysmometer (Trio-3-
in-1-Electronic System, IITC Life Science, Woodland Hills, CA,
USA; cat# 2888 and 520A) before and after surgery. For each
animal three measurements were done for each time point.
Lumbar DRG Collection
Dorsal root ganglia used for isolation of total RNA and for
Western blots were collected as previously described (Norcini
et al., 2014). Total RNA was isolated as previously described
(Norcini et al., 2014). Reverse transcription of total RNA was
done by using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems, cat#4368814). DRG used for western
blot were snap frozen upon their isolation (liquid nitrogen/dry
ice) and stored at−80◦C.
For immunohistochemistry DRG were collected as follows:
while under isoflurane anesthesia, a transcardial perfusion was
performed first with 500 ml ice cold 10% sucrose containing
Heparin (10 units/mL; Hospira Inc. Lake Forest, IL, USA)
and then with 500 ml ice cold 4% paraformaldehyde (PFA)
in phosphate-buffered saline (PBS). A ‘Perfusion TwoTM
Automate pressure Perfusion “apparatus (Leica, Microsystem;
cat# 39471005) was used to circulate these solutions. DRG were
collected and put into 4% PFA at 4◦C overnight. The next day
DRG were put into 30% sucrose at 4◦C for 1 week. The tissues
were then embedded in Tissue-Tek OCT (Sakura Finetek Inc.,
Torrance, CA, USA; cat# 25608930), fast frozen with dry ice and
stored at −80◦C. Thin sections (18 µm) were cut with a cryostat
(Leica Microsystem; Model # CM3050-S).
Immunohistochemistry
For each animal 3–4 sections from different regions within
the DRG were used. The sections were surrounded with a
PAP-PEN (Scientific Device Laboratory, Des Plaines, IL USA;
ca# 9804) and solutions were added directly on the sections.
Sections were rinsed five times with PBS and then incubated
with blocking/permeabilization solution [1% BSA, 5% serum;
Normal goat serum (NGS) or Normal Donkey serum (NDS)] and
0.4% Triton X-100) for 90 min at room temperature (RT). The
sections were incubated overnight (at 4◦C) with the following
primary antibodies: Anti-NMDAε2 Goat Polyclonal (1:100, Santa
Cruz Biotechnology, cat# sc-1469); Anti-Glutamine Synthetase
clone GS-6 Mouse Monoclonal (1:200, Millipore, cat#MAB302);
or with Iba-1 Rabbit Polyclonal (1:500, Wako, cat#019-19741)
dissolved in PBS containing 1% NDS or NGS, 1% BSA, and
0.4% Triton X-100. When using the anti- NMDAε2, the day
after, the sections were incubated with the primary antibody
for one additional hour at RT. The sections were rinsed five
times with 0.25% BSA, 0.02% Triton X-100 in PBS, and then
incubated at RT for 90 min with the corresponding secondary
antibodies (Invitrogen, Molecular Probes): Donkey Anti-Goat
Alexa Fluor 456 1:1000 (# A11036), Goat Anti-Rabbit Alexa
Fluor 488 1:1000 (# A11034) and Goat Anti-Mouse Alexa
Fluor 456 1:1000 (# A11030). The secondary antibodies were
diluted in 1% serum (NDS, NGS, or NHS), 1% BSA, and 0.02%
Triton X-100 in PBS. Sections were washed three times with
0.1% Triton X-100 in PBS and two times with PBS. Then
they were incubated with the Nissl stain (1:100, Invitrogen, #
N21480) according to the manufacturer’s protocol. When we
performed the triple immunostaining we incubated the two
primary antibodies for two consecutive nights (anti-NR2B was
always the second one). The Negative sections were incubated
only with 2% of the appropriate Serum or with IgG Goat 1:100
(Jackson ImmunoResearch, #005-000-003, working solution
0.2 mg/ml), IgG Rabbit 1:500 (Jackson ImmunoResearch, #011-
000-003, working solution of 0.3 mg/ml) and IgG Mouse 1:200
(Jackson ImmunoResearch, #015-000-003, working solution of
0.25 mg/ml) instead of the corresponding Primary Antibody.
The IgG working solutions were prepared to have the same
concentration of the working solutions of the corresponding
primary antibody. An additional negative control consisted in
the simultaneous incubation with anti-NR2B and its blocking
peptide (BP 1 µg/0.1 ml; NR2B BP cat#sc-1469-P, Santa Cruz
Biotechnology). Prior to their addition to the DRG section, the
anti-NR2B and BP were premixed (for 2 h at RT with agitation).
Coverslips were mounted using Aqua Poly/Mount (Polysciences
Inc.; cat# 18606).
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Analysis of Images
Images were captured and analyzed with a Zeiss Axiovert
200 (Carl Zeiss, Germany) inverted microscope equipped
with fluorescence and Nomarski optics, ApoTome (for optical
sections), using an Axiocam camera (Zeiss) and AxioVision
Software version 4.6.3 (Carl Zeiss imaging systems, Thornwood,
NY, USA). The pictures of the entire section were taken with a
40× objective.
Measuring NR2B Intensity Labeling
Regions of neuronal somata and satellite glial cells (SGCs) that
did not overlap with each other were located by using Nissl
staining as previously described (Castillo et al., 2013) and were
used to measure the level of NR2B labeling (Figure 1). The cells
that closely surround the neuronal somata have been identified
as SGCs by various glial markers such as with anti-glutamine
synthetase (Weick et al., 2003; Hanani, 2005; Castillo et al., 2013)
(Figures 1B–B”,b”). Within the neuronal soma NR2B labeling
is highest at the perinuclear region (Figure 1C, labeled “P”) as
we previously reported (Castillo et al., 2013). Hence, we also
measured the level of NR2B labeling in the perinuclear region
(Figure 1).
Figure 2, shows images of sections with positive staining
(Figure 2A) and for three negative controls used for
immunostaining with anti-NR2B (Figures 2B–C) as described
under immunohistochemistry. In Figure 2E, each dot, represents
the measurement of a single neuronal soma and shows that the
distribution of intensity labeling for the three negative controls
was similar. For each animal, the “intensity of NR2B labeling”
was obtained by subtracting the mean value plus standard
deviation of the intensity labeling in the “IgG negative group”
from the mean value of the intensity labeling in the “positive
group” (Figure 2E, black bracket). We found that the level of
NR2B intensity labeling in the neuronal soma was not changed
in Sham operated animals, as compared to that observed in naïve
animals (Figure 2F). Hence, for control values we pooled the
data from naïve and sham animals.
Western Blot
Dorsal root ganglia were placed in a 1:30 proportion into a
RIPA Lysis solution (Millipore, Billerica, MA, USA, # 20-188)
containing 1% Igepal (Sigma-Aldrich, CA-630), 0.1% SDS, 1:100
Protease Inhibitor Cocktail (Rockford, IL, USA, cat#78410) and
1:100 of Phosphatase Inhibitor Cocktail (Pierce, Thermo Fisher
Scientific Inc., and cat# 78420). The tissue was homogenized
using an automatic cordless motor pestle mixer (cat#K749540-
000, Kimble Chase Kontes). The suspension was left on ice for
30 min, vortexed (5–7 s) and centrifuged at 13,000 rpm for 15 min
at 4◦C. The supernatant was collected, aliquoted and stored at
−80◦C until used. Protein concentration was determined by the
Lowry Assay (Sigma-Aldrich). The sample volume containing
10–20 µg of protein was brought to a total volume of 20 µl
by adding RIPA Enriched containing Protease Inhibitor Cocktail
(1:100) and 10 µl of loading 2x tris buffer (1.25 ml of 0.5M
FIGURE 1 | The use of Nissl staining for the identification and selection of neuronal and satellite glia cell (SGC) areas that do not overlap with each
other. (A–A”) DRG section stained with Nissl (green) and with the nuclear stain Hoechst (blue). Nissl staining labels the neuronal cell bodies and the nuclei of SGCs.
The latter can be seen by the colocalization of the nuclear staining (Hoechst, blue) and the Nissl staining (green). (B–B”) DRG section immunostained with
anti-glutamine synthase (red) and stained with Nissl (green). “b” is an amplification of an area in B.” Some neurons (arrow heads) and SGCs (arrows) are indicated.
(C–C”) DRG section immunostained with anti-NR2B (red) and stained with Nissl (green). White lines show examples of the selection of neuronal “N,” perinuclear “P,”
and SGC “S” regions used to measure the level of NR2B labeling. In (c”), the light image was also overlapped. Small “c” is an amplification of an area in the above
(C, C”) pictures. Optical sections (0.86 um thick, Apotome) (A–B) and regular pictures (C). Magnification 40× objective. Scale bars 20 µm.
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FIGURE 2 | Determination of specific NR2B labeling. To determine the specific NR2B labeling, DRG sections were incubated with anti-NR2B (A) and three
negative controls were used, one in which the primary antibody (anti-NR2B) was omitted (B), another in which the primary antibody was replaced with goat IgG (C),
and the third one in which the primary antibody was pre-incubated with blocking peptide (D). (A–D) Show four panels: top left corresponds to the red signal:
NR2B-labeling + background (A) or only background (B-D). Top right: Nissl staining. Bottom left: light picture. Bottom right: overlap of the three panels. (E) Shows
intensity labeling in the red channel for the four conditions. Each dot represents a measurement from a single soma, red lines indicate the mean ± SD. Based on this
result we decided to use the negative IgG goat group to set the background value, which consisted in the average value plus one standard deviation. Specific NR2B
intensity labeling (NR2B labeling) was defined as: mean value of the “Positive group” minus the mean value + standard deviation of the “negative IgG group”
(indicated with the bracket). (F) Shows that the “NR2B labeling” for the neuronal soma was the same for Naïve and Sham rats (mean ± SEM, normalized to the
(Continued)
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FIGURE 2 | Continued
Naïve values). No significant difference was found between any of the groups (One-way ANOVA). The same was observed for SGCs and perinuclear areas between
Naïve and Sham rats (not shown). (G) The sural and tibial nerves innervate the lateral and middle areas, respectively. In sural-spared nerve injury (SNI) the sural area
is spared and the tibial-area in non-spared. In tibial-SNI the tibial area is spared and the sural area in non-spared. Rectangle indicate the non-spared regions and
ovals the spared regions for each of the SNI variants.
Tris HCl, pH 6.8, 2.5 ml Glycerol, 2.0 ml of 10% SDS, 0.2 ml
of 0.5% Bromophenol blue and 3.55 ml water). Samples were
processed and electrophoresis was run as previously described
(Castillo et al., 2011). Primary antibodies used: rabbit polyclonal
Anti-NR2B subunit (1:2000; Abcam Inc., Cambridge, MA, USA;
cat#ab14400) and goat polyclonal Anti-β-Actin (1:5000, Abcam;
cat# ab8229); and secondary antibodies used: Goat anti-Rabbit
(1:1000, cat# sc-2004) or Rabbit anti-Goat (1:10,000, cat# sc-2768;
Santa Cruz Biotechnology).
Preparation of the cDNA from Total RNA
Total RNA extraction from DRGs was done as previously
described (Norcini et al., 2014). The quality of the total RNA
samples was determined with the 2100 Bioanalyzer (Agilent
Technologies). The total RNA samples had an RNA integrity
number (RIN) between 8.4 and 9.5 (the maximum RIN
value is 10). The total RNA concentration was determined
using the NanoDrop R© ND-1000 Spectrophotometer (Thermo
Fisher Scientific), and ranged between 90.5 and 327.6 ng/µl.
We converted total RNA into cDNA by using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
cat#4368814). We performed the RT step in an Eppendorf
ep gradient S Mastercycler with a ramp speed of 6◦C/s. The
thermal-cycling conditions used were the ones suggested from
the manufactures.
RT-PCR for mRNA
The expression of the messenger RNAs for the NMDA receptor
subunits, the kinesin family member 17 (Kif17), and the
kinesin family member 5b (Kif5b) was quantified by real-
time qRT-PCR and it was performed using a CFX96 TouchTM
apparatus from BIO-RAD and MultiplateTM Low-Profile 96-Well
Unskirted PCR Plates (BIO-RAD, cat#MLL9601). TaqMan Gene
Expression Master Mix (Applied Biosystems, #4369016) was used
according to the protocol. The TaqMan Gene Expression Assays
(TaqMan Assays from Applied Biosystems, Life Technologies,
Carlsbad, CA, USA, #4331182) used are the following: Grin1:
Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1,
ID#Rn01436038_m1; Grin2A: Glutamate Receptor, Ionotropic,
N-Methyl D-Aspartate 2A, ID#Rn00561341_m1; Grin2B:
Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2B,
ID#Rn00680474_m1; Grin2C: Glutamate Receptor, Ionotropic,
N-Methyl D-Aspartate 2C, ID#Rn00561359_m1; Grin2D:
Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2D,
ID#Rn00575638_m1 and GAPDH: glyceraldehyde-3-phosphate
dehydrogenase, ID#Rn01775763_g1. Expression Assays (TaqMan
Assay from Applied Biosystems, Life Technologies, Carlsbad,
CA, USA, #4351372) was used for Kif17: ID#Rn01515647_m1;
and the (TaqMan Assay from Applied Biosystems, Life
Technologies, Carlsbad, CA, USA, #4331182) was used for
Kif5b: ID#Rn01538432. For a given sample, all reactions were
run in duplicate. Background controls consisted of replacing
the cDNA with water. Forty five cycles of amplification were
done. Data (Ct values were analyzed using a comparative 11Ct
method (Schmittgen and Livak, 2008). GAPDH was used as
the endogenous control to obtain the 1Ct value for each of the
probes within each DRG and spinal cord. GAPDH has been
validated as a stable normalization gene for qRT-PCR when
using DRG and spinal cord samples derived from the SNI model
(Piller et al., 2013). For each probe the 11Ct was obtained by
using the 1Ct experimental value (sural-SNI or tibial-SNI DRG)
minus the 1Ct control value (Sham DRG). Then the fold change
(2−11Ct) was calculated.
Statistical Analyses
Statistics were done by using GraphPad Prism vs. 6.07. One-
way ANOVA was used when comparing more than two groups,
followed by Bonferroni’s multiple comparison test or by Tukey’s
multiple comparison test. Two-way ANOVA was used when
comparing two or more groups over time. Two-way ANOVA
Ordinary was used when there was not an equal number of data
for each of the days. Two-way ANOVA Matching Stacked was
used when there was an equal number of data for each of the
days. Two-way ANOVA was followed by Bonferroni’s Multiple
comparison.
RESULTS
Both Tibial (Middle) and Sural (Lateral)
Regions of the Hindpaw Develop
Mechanical Hypersensitivity
Responses to mechanical stimulation to the middle (tibial)
and lateral (sural) regions of the hindpaws were compared
between the two SNI variants (Figure 2G). The middle region
is mostly innervated by the tibial nerve, and the lateral region
is mostly innervated by the sural nerve. The corresponding
spared and non-spared regions for each SNI are shown in
Figure 2G. The onset of mechanical hypersensitivity and
its highest level, corresponding to the lowest mechanical
threshold value, was detected on Day 1 post-surgery and
had a similar magnitude in the spared regions of both SNI
variants (Figure 3A). However, while the sural-SNI animals
maintained a low mechanical threshold throughout the entire
observation period (Figure 3A, dark blue) the tibial-SNI
animals started to recover from mechanical hypersensitivity,
as indicated by the increase in their mechanical threshold
value, at about 2 weeks and displayed almost full recovery
by Day 40 post-surgery (Figure 3A, dark green), as we
previously reported (Norcini et al., 2014). We now report
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FIGURE 3 | Differences in Mechanical Thresholds and Percentage of Paw Withdrawals between spared and non-spared regions in the tibial-SNI and
sural-SNI models. (A) Mechanical Thresholds measurements in the ipsilatereal (IL) and contralateral (CL) paws in both the spared and non-spared regions of
sural-SNI and tibial-SNI rats. No significant difference was found between the spared vs. non-spared regions in the IL paws for the tibial-SNI, neither for the
sural-SNI. Significant different: symbols in black: non-spared-IL vs. non-spared-CL for a given SNI (# tibial-SNI, ∗sural-SNI). ∗(green): spared-IL vs. spared-CL
regions in tibial-SNI. ∗(blue): spared-IL vs. spared-CL regions in sural-SNI. ∗(red): spared-IL tibial-SNI vs. spared-IL sural SNI. ∗(purple): non-spared-IL tibial-SNI vs.
non-spared-IL sural-SNI. For all the groups n = 6 rats for most days, except for Days 20, 71, and 75 where n = 3 rats, and Day 83 where n = 4 rats. One exception
is for tibial-SNI non-spared (CL and IL) that the n = 3 rats on Day 1. (B) Percentage of Paw Withdrawals in the Tibial-area (IL and CL) and Sural-area (IL and CL) in
naïve rats. No significant difference was found when comparing between groups at a given day, or within a group between 1–6 Days vs. later days; n = 3 rats.
(C) Percentage of Paw Withdrawals in the IL paws of sural-SNI and tibial-SNI. Comparison between groups at a given day: ∗(blue): spared-sural-SNI vs. non-spared
sural-SNI. No significant difference was found between spared-tibial-SNI vs. non-spared-tibial-SNI; or between spared-tibial-SNI vs. spared-sural-SNI. Within a
group between 1–6 Days vs. later days: + (black): sural-SNI (spared and non-spared); +(green) tibial-SNI (spared and non-spared). n = 6 rats (same animals as in
A). (D) Percentage of Paw Withdrawals in the CL paws of sural-SNI and tibial-SNI in the CL. For a given day, no significant difference between the sural-SNI-CL and
tibial-SNI-CL regions. Within a group between 1–6 Days vs. later days: no significance difference in tibial-SNI; + (black): sural-SNI. (E) Percentage of Paw
Withdrawals in the tibial-area (IL and CL) and sural-area (IL and CL) in Sham rats. For a given day, no significant difference was found between the groups. For a
given group, significant difference was found between 1–6 Days vs.≥50 Days for three of the groups. The fourth group, the tibial-Area-IL, significant difference was
found between 1–6 Days vs.≥65 Days. n = 4 rats; (F) Mechanical Threshold measurements in the IL and CL paws in both Sural and Tibial areas. No significant
differences were found; between groups within a given day. Two-way ANOVA Ordinary (A) and Two-way ANOVA Matching Stacked (B–F); followed by Bonferroni’s
Multiple comparison (all symbols: p < 0.05). Values are mean ± SEM.
that, within each SNI variant, the mechanical thresholds were
the same for the corresponding “spared” and “non-spared”
regions (Figure 3A, solid lines vs. dashed lines-dark green
and dark blue). However, the spared and non-spared regions
displayed qualitative differences in their mechanical response as
could be assessed by recording whether the animals displayed
a paw withdrawal. We further characterized the responses
to this mechanical stimulus by calculating the percentage of
responses that were accompanied by a paw withdrawal (% Paw
Withdrawals).
In naïve animals the “% Paw Withdrawals” showed
no significant differences among the various times points
(Figure 3B). The average “% Paw Withdrawals” in naïve rats
was ∼61% and comparable for the sural and tibial paw regions
(sural region: 60 ± 7%; tibial region: 62 ± 7%, mean ± SEM,
n = 3 rats; for each animal the value was calculated by averaging
all their values measured over time). In the sural-SNI rats, the
non-spared region (in this case corresponding to the middle
tibial area) displayed a significant decrease in the “% Paw
Withdrawals” up to Day 58 post-surgery (Figure 3C). This
decrease disappeared with time such that by Day 66 onward,
there was no significant difference between the spared and
non-spared regions in sural-SNI animals. In contrast, such
difference was not observed in the tibial-SNI model, in which
the “% Paw Withdrawals” was comparable in the spared and
non-spared regions (Figure 3C). Although within a SNI variant,
both the non-spared and spared areas displayed the same
decrease in mechanical threshold, qualitatively in the sural-SNI,
but not in the tibial-SNI, there were differences between the two
regions such that the non-spared area showed a decrease “%
Paw Withdrawals” during the first 50 days following the surgery.
This difference in “% Paw Withdrawals” disappeared over time
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 October 2016 | Volume 9 | Article 100
fnmol-09-00100 October 15, 2016 Time: 15:32 # 8
Norcini et al. SNI and DRG NR2B Expression
while the level of “Mechanical Threshold” remained low and
constant.
Interestingly, in each paw region stimulated (middle and
lateral) during the first week there was a tendency for a
decrease in the “% Paw Withdrawals,” in both the ipsilatereal (IL;
Figure 3C) and contralateral (CL; Figure 3D) paws regardless
of SNI. This decrease was also observed in the Sham group
(Figure 3E), but not in the naïve group (Figure 3B). However,
in Sham animals, the mechanical threshold was not affected
(Figure 3F). Hence, the decrease in % Paw Withdrawals within
the first week in part results from surgical procedures distinct to
nerve injury.
As indicated above, we found no correlation between the “%
Paw Withdrawals” and the “mechanical threshold value”; hence
both measurements appear to be assessing different aspects of
mechanical sensation. The “Mechanical Threshold” measures
mechanical sensitivity and the percentage of paw withdrawals
likely measures a qualitative difference in the mechanical
sensation, that appears to be related to the level of innervation
(see “Discussion” section).
In order to investigate whether the two SNI variants displayed
differences in paw inflammation, potentially induced by the
degeneration of transected fibers, we measured the volume
change of the paw. We found that there were no detectable
differences in the paw volumes between sham and either SNI
group, or between the two SNI groups, in either the IL or the CL
paws (Supplementary Figure S1). Hence, both SNI variants do
not result in detectable levels of paw edema.
NR2B Expression Is Differentially
Regulated in Sural-SNI and Tibial-SNI
Both SNI variants induce strong mechanical hypersensitivity,
but only in the sural-SNI does this behavior persist for over
3 months. Moreover, only the sural-SNI rats develop cold
hypersensitivity (Decosterd and Woolf, 2000; Norcini et al.,
2014). In the SNI models, the hypersensitivity that develops in
the rat hind paw from transecting some or all of the sciatic
nerve branches is evoked by stimulation of the nerve terminals
of the spared sciatic nerve branches and from the saphenous
nerve that become hyperexcitable as a result of interactions
with the injured sciatic nerve fibers (Kingery and Vallin, 1989;
Kingery et al., 1993; Ro and Jacobs, 1993; Attal et al., 1994;
Tal and Bennett, 1994; Guilbaud et al., 1995; Sotgiu and Biella,
1997; Campbell, 2001; Smith et al., 2013). Moreover, these fibers
(spared sciatic fibers and saphenous fibers) not only become
hyperexcitable but they also sprout and reinnervate the areas
that were denervated following transection of some of sciatic
nerve fibers. In rat, the sensory neurons of the saphenous nerve
are located mostly in the L3-DRG and those of the sciatic
nerve mostly in the L4- and L5-DRG. Based on the composition
of afferent fibers within each of the sciatic nerve branches
(Swett et al., 1991), L4 DRG contains the highest number
and percentage of injured primary sensory neurons following
sural-SNI (Table 1). Hence, we measured NR2B expression in
L3-DRG and L4-DRG. We selected Day 23 and Day 86 post-
injury to measure NR2B labeling because significant behavioral
differences between the two models are evident. At Day 23,
TABLE 1 | The number of sensory fibers within each of the sciatic nerve branches (peroneal, tibial, sural) that contributes to each of the Dorsal root
ganglias (DRGs; L3, L4, and L5) was taken from (Swett et al., 1991).
Sural-SNI Tibial-SNI Sensory neurons1
# (%) Injured sensory neurons # (%) Injured sensory neurons #neurons (% of a given sciatic
nerve branch)1
#sensory neurons in DRG
mean2,3
L3-DRG1 113(∼0.8%) 65 (∼0.5%) 65 (2.4% of peroneal)
48 (1.0% of tibial)
0 (0% of sural)
L4-DRG1 5,367 (43%) 2,208 (18%) 2133 (79% of peroneal) 12,496 (12,000–12,991)
3234 (68.1% of tibial)
75 (4.5% of sural)
L5-DRG1 1,967 (13%) 2065 (13%) 501 (18.6% of peroneal) 15,321 (15,000–15642)
1466 (30.9% of tibial)
1564 (93.4% of sural)
#/type neurons injured in each SNI 7,447 sensory (68%)1 4,338 sensory (39%)1
1,614 motor 700 motor
13,200 sensory3 8,200 sensory3
1,600 motor 600 motor
4,800 sympathetic 2,600 sympathetic
Sprague–Dawley rats: 1(Swett et al., 1991) and 2(McKay Hart et al., 2002). Wistar rats: 3(Schmalbruch, 1986). To estimate the percentage of injured sensory neurons
within each DRG we used the total number of sensory neurons reported for the L4-DRG and L5-DRG in two studies (Schmalbruch, 1987; McKay Hart et al., 2002). Since
no values were available for L3-DRG we used an average value of those reported for the L4-L5 DRG (13,908). Although those two studies used different rat species
(Sprague–Dawley and Wistar rats), they found a comparable number of sensory neurons within the DRG and of motor fibers within the various sciatic nerve branches.
However, the number of sensory fibers within each of the sciatic nerve branches was very different, being almost double in Wistar rats than in Sprague–Dawley rats. We
are showing the values from the Schmalbruch study, since it also provides us with the number of sympathetic fibers within each of the sciatic nerve branches, which
allowed us to provide an estimate of the number of sympathetic fibers that would be expected to be injured in both spared nerve injurys (SNIs). This was done to help us
in the discussion.
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while there is 50% recovery in mechanical thresholds, and no
cold allodynia in tibial-SNI rats, sural animals display strong
mechanical and cold hypersensitivity. At Day 86, tibial-SNI rats
fully recover, while thermal and mechanical hypersensitivities
persist in the sural-SNI rats (Figure 3A). Thus, Day 23 and
Day 86 measurements of NR2B expression provide information
regarding how changes in this subunit is correlated with recovery
or persistent pain.
In L3-DRG, at Day 23 post-surgery there were no significant
differences in the level of NR2B labeling (in red) in the neuronal
somata and SGCs between either tibial-SNI or sural-SNI and the
control group (Figures 4A–C and 5A,C,E). In contrast, at Day
86 post-surgery, there was an increase in the intensity of NR2B
labeling in the neuronal somata and SGCs from tibial-SNI but
not from sural-SNI (Figures 4D–F and 5B,F). The increase in
NR2B labeling in the neuronal somata is primarily found within
the perinuclear region of the neuron (Figures 5B vs. 5D).
The presence of small cells with intense NR2B labeling
were also observed, and were morphologically distinct from
SGCs and neurons (Figure 4, some indicated with “∗”). Co-
labeling with anti-Iba-1 (green) confirmed that these NR2B-
positive cells (red) are microglia/macrophages (Figures 6A,B,
green, and circles); however, not all Iba-1 positive cells expressed
NR2B (arrows; Figures 6A,B). At Day 23, an increase in
the number of microglia/macrophage cells that were NR2B-
positive were observed in the ipsilateral DRG of sural-SNI
and tibial-SNI rats (Figures 6C–E and 5G). This increase was
transitory since it became undetectable on Day 86 post-surgery
(Figure 5H).
In contrast to L3-DRG, the neuronal somata and SGCs did not
show significant changes in NR2B labeling in L4-DRG at Day 86
post-surgery (Figure 7).
Though fluorescence analysis of stained tissue sections
demonstrated cell-specific and localized changes of NR2B
labeling, significant NR2B differences were not detectable
through Western Blot of whole DRG cell lysates of individual
L3-DRG and L4-DRG (Supplementary Figures S2A,B). In
addition to the neuronal somata, the SGCs and microglia,
a large proportion of the DRG are comprised of fibers
(Supplementary Figure S2C). Many of these fibers are also
myelinated by Schwann cells, which recently have been shown
to also express NR2B (Mantuano et al., 2015). The presence
of these various cell types, together with the difference
in contribution of the nerve fibers likely complicated the
detection of differences in NR2B expression when using Western
Blotting.
FIGURE 4 | NR2B intensity labeling in L3-DRG at Day 23 and Day 86 following surgery. L3 DRG sections were immunostained with anti-NR2B (red) and
stained with Nissl (green) at Day 23 for control (A), Sural-SNI (B) and Tibial-SNI (C) and at Day 86 for control (D), Sural-SNI (E), and Tibial-SNI (F). Top panels only
show NR2B intensity labeling (background has been substracted) (A–F); middle panels show NR2B intensity labeling (red) and Nissl staining (green) (A’–F’); and
bottom panels shows the corresponding light pictures (A”–F”). Magnification 40× objective. Scale bars: 20 µm.
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FIGURE 5 | Quantification of NR2B labeling in various cells in the L3-DRG at Day 23 and Day 86 following surgery. NR2B labeling in the neuronal soma
(SOMA) (A,B), the perinuclear area of the neuronal soma (E,C), in SGC (E,F) and in microglia/macrophages (G,H) at Day 23 (A,C,E,G) and Day 86 (B,D,F,H)
following surgery. For Day 23 (A,C,E,G): the control group n = 6 rats (three sham, three naïve). For each control rat measurements were done in the IL and CL
L3-DRG. Measurements were done in on average in 198 somas/rat (A); on average in 198 perinuclear areas/rat (C); on average in 120 SGCs/rat (E). For the other
four groups (Sural-SNI-IL, Sural-SNI-CL, Tibial-SNI-L, and Tibial-SNI-CL) n = 3 rats. The “average number of somas/rat-area” measured were 116, 101, 111, 109
for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI IL, and Tibial-SNI CL, respectively. The “average number of perinuclear areas/rat-area” measured were 109, 100, 102. 92
for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI IL, and Tibial-SNI CL, respectively. The “average number of SGCs/rat-area” measured were 72, 62, 66, 60 for Sural-SNI-IL,
Sural-SNI CL, Tibial-SNI L, and Tibial-SNI CL, respectively. For Day 86 (B,D,F,H): the control group n = 4 rats (two sham, two naïve). For each control rat
measurements were done in the IL and CL L3-DRG. Measurements were done in on average in 256 somas/rat (B); on average in 257 perinuclear areas/rat (D); on
average in 360 SGCs/rat (F). For the other four groups (Sural-SNI-IL, Sural-SNI-CL, Tibial-SNI-L, and Tibial-SNI-CL) n = 3 rats. The “average number of somas/rat”
measured were 148, 124,122, and 166 for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI IL, and Tibial-SNI CL, respectively. The “average number of perinuclear areas/rat”
measured were 148, 137,143, and 190 for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI IL, and Tibial-SNI CL, respectively. The “average number of SGCs/rat” measured
were 270, 154, 209, and 256 for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI L, and Tibial-SNI CL, respectively. (G,H) Number of microglia/macrophages that were NR2B
positive/324,000 µm2. The n = 6 and 4 rats for Day 23 and Day 86, respectively; and n = 3 rats for all the other groups. In all panels: mean + sem. For (A–F), the
data was normalized to control values. One-way ANOVA, with Tukey’s multiple comparison test. ∗p < 0.001, +p < 0.01, ˆp < 0.05.
Expression of mRNA Encoding the
Various NMDA Receptor Subunits at Day
86 Post-surgery
Since a significant difference in NR2B labeling was detected only
at Day 86 post-surgery between sural-SNI and tibial-SNI, this
time point was chosen to also measure mRNA expression for
the various NMDA receptor subunits in DRG and in spinal cord
tissue by using qPCR. We found that NR2B (Grin 2B) subunit
transcripts were up-regulated only in the ipsilateral L4-DRG
of sural-SNI (Figure 8B). Transcripts for NR1 (Grin1), NR2A
(Grin2A), NR2D (Grin2D), NR2C (Grin 2C) subunits were not
changed in L3-DRG, L4-DRG, or L5-DRG (Figure 8). Moreover,
no significant changes were observed in the mRNA for NR1
(Grin1) or NR2B (Grin 2B) in the lumbar spinal cord relative to
shams (Figure 8F).
Expression of mRNA Encoding for the
Kinesin Family Member 17 (Kif17) and
Family Member 5b (Kif5b)
We measured the mRNA expression of the kinesins KIF17
and KIF5B to investigate whether they could contribute to the
observed changes in NR2B expression between sural-SNI and
tibial-SNI, at Day 86 post-surgery. Kinesins are microtubule
associated molecular motors that transport cargos (vesicles,
proteins, mRNAs) along microtubules mostly in the anterograde
direction (Schnapp, 2003). Of the 47 kinesins identified in
mammals, Kif17 is involved in the anterograde transport to
dendrites of various proteins including the NR2B subunit (Setou
et al., 2000; Wong-Riley and Besharse, 2012); and Kif5b is
important in axonal transport (Hirokawa et al., 2010). We found
that KIF17 transcripts were down-regulated only in the ipsilateral
L4-DRG of sural-SNI (Figure 9A), but no change was found in
the level of Kif5b transcripts (Figure 9B).
DISCUSSION
We found that the electronic von Frey allows for the detection of
mechanical hypersensitivity in the spared and non-spared regions
of the hindpaws; however, these regions showed qualitative
differences in their responses. We also observed nerve injury-
induced changes in NR2B expression in neurons, SGCs and
microglia/macrophages of the un-injured L3-DRG and injured
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FIGURE 6 | Identification of microglia/macrophages. (A) DRG section immunostained with anti-Iba-1 (green) a microglia/macrophage marker and stained with
the nuclear stain Hoechst (blue). Both Iba-1+/NR2B+ cells (circles) and Iba-1+/NR2B- cells (arrows) were detected. The corresponding light picture is also shown.
(B) shows the overlap of the color images in (A). DRG sections immunostained with anti-NR2B (red) and stained with Nissl (green) from a control (C) Sural-SNI (D)
and Tibial-SNI (E) L3-DRG at Day 23 post-surgery. (A–B) Conventional pictures and (C–E) optical sections (0.86 µm thick, Apotome). Magnification 40× objective.
Scale bars: 20 µm.
L4-DRG. Hence changes in NR2B expression within the DRG
appear to affect neuronal and glial function, and may contribute
to the neuropathic pain phenotype in SNI.
Stimuli-Evoked Hypersensitivity
The sural and tibial nerves innervate the lateral and middle
regions of the hindpaws, respectively, but there is also spatial
overlap (Duraku et al., 2012). Hence, to a different extent, both
regions maintain a level of innervation following SNI. With the
manual von-Frey, mechanical hypersensitivity is detected only
in the sural region following sural-SNI (Duraku et al., 2012,
2013; Nascimento et al., 2015). With the electronic von-Frey,
we detected mechanical hypersensitivity in both regions. The
manual system uses a set of filaments of varying diameters so
as to provide a range of forces (g) (Bradman et al., 2015).
With the manual system a mechanical response is detected with
thin fibers (0.229–0.254 mm diameter, ∼1.202–1.479 g) in sural-
SNI animals; but only with a thick fiber (0.483 mm diameter,
∼15.136 g) in sham animals1 (Wang et al., 2011). The electronic
von Frey system used in this study only uses one filament with
a 0.8 mm tip diameter, hence a constant area is stimulated
and the only variable is the applied pressure. The detection of
mechanical hypersensitivity in the highly denervated region may
in part reflect the stimulation of a relatively larger area when
using the electronic system rather than when using the manual
one.
1http://www.stoeltingco.com/media/wysiwyg/58011_Touch_Test_Evaluator.pdf
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FIGURE 7 | Quantification of NR2B labeling in various cells in the L4-DRG at Day 86 following surgery. NR2B labeling in the neuronal soma (SOMA) (A),
the perinuclear area of the neuronal soma (B), in SGC (C) and in microglia/macrophages (D) at Day 86 following surgery. The control group n = 5 rats (three naïve
and two sham). For each control rat measurements were done in the IL and CL L4-DRG. Measurements were done in on average in 803 somas/rat (A); on average
in 564 perinuclear areas/rat (B); on average in 576 SGCs/rat (C). For the other four groups (Sural-SNI-IL, Sural-SNI-CL, Tibial-SNI-L, and Tibial-SNI-CL) n = 3 rats.
The “average number of somas/rat-area” measured were 294, 558, 358, and 396 for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI IL, and Tibial-SNI CL, respectively. The
“average number of perinuclear areas/rat-area” measured were 176, 351, 169, and 181 for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI IL, and Tibial-SNI CL, respectively.
The “average number of SGCs/rat-area” measured were 243, 285, 232, 204 for Sural-SNI-IL, Sural-SNI CL, Tibial-SNI L, and Tibial-SNI CL, respectively.
(D) Number of microglia/macrophages that were NR2B positive/324,000 µm2. The n = 5 for control and and n = 3 rats for all the other groups. In all panels:
mean + SEM. For (A–C), the data was normalized to control values. One-way ANOVA.
In sural-SNI, the non-spared and spared regions displayed
the same decrease in mechanical threshold, while the non-
spared region displayed a lower percentage paw withdrawals.
However, the “% Paw Withdrawals” slowly increased, and by
Day 65 was similar to that of the spared region. This gradual
increase in the “% Paw Withdrawals” roughly correlates with
the reported time course of reinnervation by sensory fibers
(Duraku et al., 2012, 2013). Therefore, in sural-SNI there
is a qualitative difference in the mechanical hypersensitivity
in these two paw regions, which appears to be related to
the level of innervation. In tibial-SNI, the non-spared and
spared regions displayed a transient decrease in mechanical
threshold, while the “% Paw Withdrawals” was comparable
to those in sham animals. Based on the fiber composition
of the sciatic nerve (Swett et al., 1991) a lower percentage
of afferent fibers are injured following tibial-SNI compared
to sural-SNI (39% vs. 68%; Table 1). Hence a decrease
in “% Paw Withdrawals” requires a high level of sensory
denervation.
No correlation was found between the “Mechanical
Threshold” and the “% Paw Withdrawals”; hence both
measurements assess different aspects of mechanical sensation.
While “Mechanical Threshold” measures the mechanical
sensitivity, the “% Paw Withdrawals” appears to be related and
proportional to the level of sensory innervation. By combining
both measurements, one could obtain information regarding the
overall increase in mechanical hypersensitivity. In sural-SNI,
both the spared and non-spared regions showed a slow continual
increase in overall mechanical hypersensitivity, with the spared
region showing a highest value and the strongest increase; while
in tibial-SNI both regions displayed a transient and comparable
increase in overall mechanical hypersensitivity.
Mechanical hypersensitivity displayed by both SNIs
appears to primarily involve changes in primary sensory
neurons, but it may also involve changes in sympathetic
neurons. The number of damaged sympathetic neurons
is twice as high in sural-SNI than in tibial-SNI (Table 1).
In the sural-SNI sympathetic neurons contribute to cold
hypersensitivity; but their reported contribution to mechanical
hypersensitivity depends on the protocol used for chemical
sympathectomy (Pertin et al., 2007; Nascimento et al.,
2015).
DRG NR2B Expression
We used the different neuropathic pain phenotype between the
sural-SNI and tibial-SNI to investigate whether changes in NR2B
expression within the DRG correlated with the development of
sustained hypersensitivity following a sciatic nerve injury. We
selected Day 23 and Day 86 to measure NR2B labeling, because
in tibial-SNI at Day 23 there is 50% recovery and at Day 86 there
is full recovery in injury-induced mechanical hypersensitivity,
while sural-SNI displays strong mechanical hypersensitivity at
both time points.
At Day 86 an increase in NR2B mRNA was observed
only in sural-SNI; hence this upregulation correlates with the
development of sustained hypersensitivity. Interestingly, this
increase was not accompanied by an increase in NR2B protein
in the DRG, suggesting that the mRNA increase may be
accompanied by an accelerated transport of NR2B protein away
from the soma. To investigate this possibility we measured the
level of kinesin Kif17. In central neurons Kif17 is involved in
the transport into dendrites of various proteins including the
NR2B subunit (Setou et al., 2000). Kif17 protein has not been
detected in the sciatic nerve (Setou et al., 2000) and primary
sensory neurons do not have dendrites. Hence in primary sensory
neurons Kif17 most likely is involved in transporting NR2B to
the soma’s plasma membrane. Here we found that the expression
of Kif17 transcripts was decreased only in sural-SNI. Because
of the observed increase in NR2B mRNA, we expect that there
should be an increase in NR2B protein production. The observed
lack of a change in the measured NR2B protein level within
the soma appears to result in part from a decrease in Kif17
which will result in a decrease in NR2B transport to the soma’s
plasma membrane. The results also suggest that there may be
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FIGURE 8 | qPCR for the various NMDAr subunits in DRG and spinal cord derived from sural-SNI and tibial-SNI. (A–E) For DRG, n = 4 rats, except for
two groups in Grin1 DRG5 (sural-SNI IL and tibial-SNI CL) n = 3. (F) For Spinal cord, n = 3 rats. For each probe the 11Ct was obtained by using the 1Ct
experimental value (sural-SNI or tibial-SNI DRG) minus the 1Ct control value (Sham DRG). Then the fold change (2−11C t ) was calculated. Values are mean + SEM.
One-way ANOVA, tukey’s multiple comparison test. ∗p < 0.05.
an increase in axonal transport of NR2B protein away from
the soma toward the plasma membrane of fibers and/or nerve
terminals and in this way contribute to their hyperexcitability.
To our knowledge there is no available information of which
kinesin(s) are involved in axonal transport of NR2B, however,
we measured the expression of Kif5b since it has been shown
to be important in axonal transport of various ion channels and
receptors (Rivera et al., 2007; Hirokawa et al., 2010; Twelvetrees
et al., 2010; Su et al., 2013). We found that the expression of
Kif5b transcripts was not changed. Whether the decrease in
Kif17 may promote axonal transport by increasing the availability
of NR2B protein to be taken up by axonal transporters, or
whether there is an increase in other molecules that mediate
axonal transport of NR2B remains to be determined. However,
the increase in NR2B mRNA in injured primary sensory neurons
correlates with the development of sustained hypersensitivity in
sural-SNI.
In sural-SNI, the increase in NR2B mRNA was observed
only in L4-DRG, hence enhanced NR2B transcription may
be triggered only when a large proportion of sensory fibers
are injured (Table 1). The hypersensitivity that develops in
the rat hind paw from transecting some or all of the sciatic
nerve branches is evoked by stimulation of the nerve terminals
of the spared sciatic nerve branches (L4-L5 DRG) and from
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FIGURE 9 | qPCR for Kif17 and Kif5b in DRG derived from sural-SNI
and tibial-SNI. DRG, n = 4 rats. For each probe the 11Ct was obtained by
using the 1Ct experimental value (sural-SNI or tibial-SNI DRG) minus the 1Ct
control value (Sham DRG). Then the fold change (2−11C t ) was calculated. (A)
Kif17, (B) Kif5b. Values are mean + SEM. One-way ANOVA, tukey’s multiple
comparison test. ∗p < 0.05.
the saphenous nerve (L3-DRG) that become hyperexcitable as
a result of interactions with the injured sciatic nerve fibers
(Kingery and Vallin, 1989; Kingery et al., 1993; Ro and Jacobs,
1993; Attal et al., 1994; Tal and Bennett, 1994; Guilbaud
et al., 1995; Sotgiu and Biella, 1997; Campbell, 2001; Smith
et al., 2013). Our results indicate that upregulation of NR2B
mRNA may directly contribute to the hypersensitivity of primary
sensory neurons located in DRG containing a high number of
damaged neurons (L4-DGR) but not to those located in DRG
containing a low number of damaged neurons (L3 and L5
DRG).
There was no upregulation of NR2B mRNA in tibial-SNI
which correlates with the lack of development of sustained
hypersensitivity. Moreover, in tibial-SNI, at Day 86, but not at
Day 23 a significant upregulation of NR2B protein was detected
within the perinuclear region of the neuronal soma and only
in L3-DRG, which contain mostly uninjured saphenous sensory
neurons. Uninjured saphenous sensory neurons also become
hyperexcitable following injury to the sciatic nerve (Kingery et al.,
1993; Ro and Jacobs, 1993; Attal et al., 1994; Guilbaud et al.,
1995; Sotgiu and Biella, 1997; Smith et al., 2013). The increase
in NR2B protein within the perinuclear region, in the absence
of a change in NR2B mRNA, indicates that there is retention
and slowing of NR2B transport away from the perinuclear region
toward the neuronal plasma membrane. The decrease of NR2B
protein transport to the neuronal plasma membrane, would
render them non-functional and by doing so would decrease their
contribution to neuronal excitability and this may contribute to
the recovery of tibial-SNI animals.
In both SNIs, microglia/macrophages showed a transient
increase in NR2B protein observed on Day 23 but not on Day
86. This may be related to the reported microglia/macrophage
activation following sciatic nerve injuries (Lu and Richardson,
1993; Fenzi et al., 2001; Hu et al., 2007; Vega-Avelaira et al.,
2009). Since this transient increase was observed in both
SNIs, microglia/macrophage NR2B upregulation may contribute
to initial post-injury induced hypersensitivity, but it would
appear to not be sufficient for the development of sustained
hypersensitivity. At Day 86, but not at Day 23, SGCs displayed
an increase in NR2B protein only in tibial-SNI. SGCs become
activated following sural-SNI (Xie et al., 2009). Many of
the reported injury-evoked alterations in SGCs contribute to
neuropathic pain (Hanani et al., 2002; Dublin and Hanani, 2007;
Liu et al., 2012); but SGCs could also undergo changes that
contribute to recovery. One such alteration could be the increase
in NR2B protein since it was observed only in tibial-SNI. How
the increase in NR2B expression in SGCs contributes to recovery
remains to be determined, but it could involve interactions
between SGCs and neurons.
It is known that pain perception shows sex differences
(Holdcroft et al., 2000; Ji et al., 2006; Meleine and Matricon,
2014). Moreover, sex hormones have been shown to modulate the
somatic sensitivity to nociceptive stimuli (Bradesi et al., 2003; Ji
et al., 2003; Sanoja and Cervero, 2005; Nag and Mokha, 2016).
This hormonal modulation in part involves regulation of various
ion channels and receptors (Lee et al., 2002; McRoberts et al.,
2007; Tang et al., 2008; Cho and Chaban, 2012; Ji et al., 2012);
including the NMDAr in DRG neurons (McRoberts et al., 2007).
Hence additional experiments will be required to determine
whether the observations in this study using male rats can be
extended to female rats.
In summary, the transient increase of NR2B protein
expression in microglia/macrophages correlates with the initial
post-injury induced hypersensitivity observed in both SNIs. The
increase in NR2B mRNA correlates with the development of
sustained hypersensitivity in sural-SNI. The lack of NR2B mRNA
increase, together with the retention of NR2B protein within
the perinuclear region of the neuronal soma correlates with the
recovery from hypersensitivity in Tibial-SNI.
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FIGURE S1 | The paw volume was not affected by Tibial-SNI or Sural-SNI.
The paw volume was measured both in the IL (A) and CL (B) paws in Tibial-SNI
and Sural-SNI rats at the indicated dates. For a given rat the measurement was
normalized to the baseline (BL) measurement that was taken the day of the
surgery, prior to anesthetizing the animal. No significant difference between
groups for a given day. One-way ANOVA (p = 0.0055); Bonferroni’s Multiple
comparison post-test.
FIGURE S2 | Western blot of NR2B for L3-DRG and L4-DRG. (A) Western
blot for NR2B indicating the NR2B and β-Actin bands of samples from L3-DRG.
β-Actin was used to control for the amount of protein loaded. a, naïve IL, b, sham
L3 IL, c, Sural-SNI IL, d, Tibial-SNI IL, a’, naïve CL, b’, sham CL, c’, Sural-SNI CL,
d’, Tibial-SNI CL. (IL, ipsilateral, CL, contralateral). (B) The normalized amount of
NR2B protein (NR2B/β-Actin) normalized to the values obtained in sham (control)
animals. n: 4 rats No significant difference between each SNI vs. control, or
Sural-SNI vs. Tibial-SNI, in either L3-DRG or L4-DRG. One-way ANOVA. (C) Low
magnification picture (10×) of a DRG section stained with Nissl (green). Scale bar:
50 µm.
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